一个贝叶斯框架,通过整合多种类型的基因组数据来引导癌症亚组的路径识别
Zequn Sun1, Dongjun Chung2,3, Brian Neelon4
1Department of Preventive Medicine, Northwestern University, Chicago, Illinois.
Statistics in medicine
|September 16, 2023
概括
贝叶斯-InGRiD整合了多种癌症数据,以识别患者子组和关键分子特征. 这种途径导向的方法增强了个性化医学的生物解释.
科学领域:
- 计算生物学是一种计算生物学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 像TCGA这样的综合癌症基因组学平台产生了大量的多omics数据 (基因表达,拷贝数,甲基化,突变).
- 现有的方法往往侧重于基因水平分析,限制途径水平的生物见解和个性化医学应用.
研究的目的:
- 介绍Bayes-InGRiD,一个新的路径引导的贝叶斯稀疏潜伏因子模型.
- 在统一的框架内,同时识别癌症患者的子组 (聚类) 和关键分子特征 (变量选择).
- 为了提高多omics数据分析的准确性,稳定性和生物解释性.
主要方法:
- 开发了一种路径引导的贝叶斯稀疏隐性因子模型,用于连续,二进制和计数数据的联合分析.
- 利用路径 (基因组) 信息来指导整合性基因组学分析.
- 提出了一种高效的Gibbs采样器,使用Pólya-Gamma混合物对二进制和计数数据进行后置采样.
主要成果:
- 贝叶斯-InGRiD提高了癌症患者子组和关键分子特征的识别准确性和稳定性.
- 路径导向的方法促进了对多学科数据的更深入的生物学理解和解释.
- 该方法是在GitHub上可用的R包"INGRID"中实现的.
结论:
- 贝叶斯-InGRiD提供了一个统一的框架,用于在癌症研究中强大的多学科数据集成.
- 途径导向的方法为个性化癌症医学提供了生物学上有意义的发现.
- 开发的R包为研究人员提供了一种实用工具,可以应用这种新的方法.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381


